Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Alessandro Re, MD, Mariagrazia Michieli, MD, Chiara Cattaneo, MD, Maurizio Rupolo, MD, Salvatore Casari, MD, Michele Spina, MD, Bernardino Allione, MD, Camillo Almici, MD, Piero Ferremi, MD, Luciano Abruzzese, MD, Cecilia Simonelli, MD, Rosa Manuele, MD, Alessandro Levis, MD, Giampiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2007) 110 (11): 23.

https://doi.org/10.1182/blood.V110.11.23.23

Published: 2007

Journal Articles

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

Cecilia Simonelli, MD, Michele Spina, MD, Chiara Pratesi, ScD, Rosamaria Tedeschi, ScD, Maurizio Rupolo, MD, Maria Teresa Bortolin, ScD, Stefania Zanussi, ScD, Mariagrazia Michieli, MD, Paolo De Paoli, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 2933.

https://doi.org/10.1182/blood.V106.11.2933.2933

Published: 2005

Journal Articles

Identification of Eight Surface Molecules with Survival Predictive Power in B Cell Chronic Lymphocytic Leukemia (B-CLL): A Proposal for a Scoring System.

Valter Gattei, MD, Paolo Sonego, PhD, Stefania Russo, BSci, Riccardo Bomben, BSci, Michele Dal Bo, BSci, Maurizio Rupolo, MD, Giovanni Del Poeta, MD, Carlo Pucillo, MD, Alfonso Colombatti, MD, Massimo Degan, BSci, Antonella Zucchetto, BSci

Blood (2004) 104 (11): 2797.

https://doi.org/10.1182/blood.V104.11.2797.2797

Published: 2004

Journal Articles

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

Maurizio Rupolo, MD, Mariagrazia Michieli, MD, Michele Spina, MD, Daniele Bernardi, MD, Massimiliano Berretta, MD, Annalisa Giacalone, Psic, Umberto Tirelli, MD

Blood (2004) 104 (11): 5216.

https://doi.org/10.1182/blood.V104.11.5216.5216

Published: 2004

Journal Articles

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Maurizio Rupolo, MD, Michele Spina, MD, Mariagrazia Michieli, MD, Massimiliano Berretta, MD, Luciano Abbruzzese, MD, Mario Mazzucato, MD, Valter Gattei, MD, Umberto Tirelli, MD

Blood (2004) 104 (11): 1323.

https://doi.org/10.1182/blood.V104.11.1323.1323

Published: 2004

Journal Articles

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Alessandro Re, MD, Chiara Cattaneo, MD, MariaGrazia Michieli, MD, Salvatore Casari, MD, Michele Spina, MD, Maurizio Rupolo, MD, Bernardino Allione, MD, Piero Ferremi, MD, Arnalda Lanfranchi, PhD, Mauro Mazzuccato, MD, Gianpiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2004) 104 (11): 893.

https://doi.org/10.1182/blood.V104.11.893.893

Published: 2004

NARROW

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

Identification of Eight Surface Molecules with Survival Predictive Power in B Cell Chronic Lymphocytic Leukemia (B-CLL): A Proposal for a Scoring System.

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

Identification of Eight Surface Molecules with Survival Predictive Power in B Cell Chronic Lymphocytic Leukemia (B-CLL): A Proposal for a Scoring System.

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only